CBDX (Curative Biosciences) Scaled Net Operating Assets: -369.00 (As of Mar. 2018)


What is Curative Biosciences Scaled Net Operating Assets?

Curative Biosciences CBDX Scaled Net Operating Assets is -369.00 as of Mar. 2018.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Curative Biosciences's operating assets for the quarter that ended in Mar. 2018 was $0.01 Mil. Curative Biosciences's operating liabilities for the quarter that ended in Mar. 2018 was $0.38 Mil. Curative Biosciences's Total Assets for the quarter that ended in Dec. 2017 was $0.00 Mil. Therefore, Curative Biosciences's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2018 was -369.00.

Curative Biosciences Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Curative Biosciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences Scaled Net Operating Assets Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.12 -3.08 -43.63 -56.50 -113.60

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -153.25 -189.33 -323.50 -337.00 -369.00

CBDX vs ACUR, CVLB, RDGL: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curative Biosciences Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's Scaled Net Operating Assets falls into.


Curative Biosciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Curative Biosciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2017 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jun. 2017 )
=(Operating Assets (A: Jun. 2017 )-Operating Liabilities (A: Jun. 2017 ))/Total Assets (A: Jun. 2016 )
=(0.002-0.57)/0.005
=-113.60

where

Operating Assets(A: Jun. 2017 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.002 - 0
=0.002

Operating Liabilities(A: Jun. 2017 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.633 - 0 - 0.063
=0.57

Curative Biosciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2018 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2018 )
=(Operating Assets (Q: Mar. 2018 )-Operating Liabilities (Q: Mar. 2018 ))/Total Assets (Q: Dec. 2017 )
=(0.013-0.382)/0.001
=-369.00

where

Operating Assets(Q: Mar. 2018 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.014 - 0.001
=0.013

Operating Liabilities(Q: Mar. 2018 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.72 - 0 - 0.338
=0.382

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -369.00 mean?
Curative Biosciences (CBDX) has a Scaled Net Operating Assets of -369.00 as of Mar. 2018. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Curative Biosciences and its competitors.
Is Curative Biosciences' Scaled Net Operating Assets too high?
Curative Biosciences' current Scaled Net Operating Assets is -369.00.
How does Curative Biosciences' Scaled Net Operating Assets compare to ACUR and CVLB?
Curative Biosciences' Scaled Net Operating Assets of -369.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Curative Biosciences and its competitors. Curative Biosciences's current Scaled Net Operating Assets is -369.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biosciences stock overvalued right now?
Curative Biosciences (CBDX) has a current Scaled Net Operating Assets of -369.00. The current Scaled Net Operating Assets is -369.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Curative Biosciences (CBDX), the current Scaled Net Operating Assets is -369.00 as of Mar. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biosciences Business Description

Address 2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.